Adit A Ginde1, Roy G Brower1, Jeffrey M Caterino1, Lani Finck1, Valerie M Banner-Goodspeed1, Colin K Grissom1, Douglas Hayden1, Catherine L Hough1, Robert C Hyzy1, Akram Khan1, Joseph E Levitt1, Pauline K Park1, Nancy Ringwood1, Emanuel P Rivers1, Wesley H Self1, Nathan I Shapiro1, B Taylor Thompson1, Donald M Yealy1, Daniel Talmor1. 1. The affiliations of the members of the writing committee are as follows: the Department of Emergency Medicine, University of Colorado School of Medicine, Aurora (A.A.G., L.F.); the Department of Medicine, Johns Hopkins University School of Medicine, Baltimore (R.G.B.); the Department of Emergency Medicine, Ohio State University, Columbus (J.M.C.); the Departments of Anesthesia, Critical Care, and Pain Medicine (V.M.B.-G., D.T.) and Emergency Medicine (N.I.S.), Beth Israel Deaconess Medical Center, and the Biostatistics Center (D.H.) and the Department of Medicine (N.R., B.T.T.), Massachusetts General Hospital - all in Boston; the Department of Medicine, Intermountain Medical Center and the University of Utah, Salt Lake City (C.K.G.); the Department of Medicine, University of Washington, Seattle (C.L.H.); the Departments of Medicine (R.C.H.) and Surgery (P.K.P.), University of Michigan, Ann Arbor; the Department of Emergency Medicine and Surgery, Henry Ford Hospital, Detroit (E.P.R.); the Department of Medicine, Oregon Health and Science University, Portland (A.K.); the Department of Medicine, Stanford University, Palo Alto, CA (J.E.L.); the Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville (W.H.S.); and the Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh (D.M.Y.).
Abstract
BACKGROUND:Vitamin D deficiency is a common, potentially reversible contributor to morbidity and mortality among critically ill patients. The potential benefits of vitamin D supplementation in acute critical illness require further study. METHODS: We conducted a randomized, double-blind, placebo-controlled, phase 3 trial of early vitamin D3 supplementation in critically ill, vitamin D-deficient patients who were at high risk for death. Randomization occurred within 12 hours after the decision to admit the patient to an intensive care unit. Eligible patients received a single enteral dose of 540,000 IU of vitamin D3 or matched placebo. The primary end point was 90-day all-cause, all-location mortality. RESULTS: A total of 1360 patients were found to be vitamin D-deficient during point-of-care screening and underwent randomization. Of these patients, 1078 had baseline vitamin D deficiency (25-hydroxyvitamin D level, <20 ng per milliliter [50 nmol per liter]) confirmed by subsequent testing and were included in the primary analysis population. The mean day 3 level of 25-hydroxyvitamin D was 46.9±23.2 ng per milliliter (117±58 nmol per liter) in the vitamin D group and 11.4±5.6 ng per milliliter (28±14 nmol per liter) in the placebo group (difference, 35.5 ng per milliliter; 95% confidence interval [CI], 31.5 to 39.6). The 90-day mortality was 23.5% in the vitamin D group (125 of 531 patients) and 20.6% in the placebogroup (109 of 528 patients) (difference, 2.9 percentage points; 95% CI, -2.1 to 7.9; P = 0.26). There were no clinically important differences between the groups with respect to secondary clinical, physiological, or safety end points. The severity of vitamin D deficiency at baseline did not affect the association between the treatment assignment and mortality. CONCLUSIONS: Early administration of high-dose enteral vitamin D3 did not provide an advantage over placebo with respect to 90-day mortality or other, nonfatal outcomes among critically ill, vitamin D-deficient patients. (Funded by the National Heart, Lung, and Blood Institute; VIOLET ClinicalTrials.gov number, NCT03096314.).
RCT Entities:
BACKGROUND:Vitamin D deficiency is a common, potentially reversible contributor to morbidity and mortality among critically illpatients. The potential benefits of vitamin D supplementation in acute critical illness require further study. METHODS: We conducted a randomized, double-blind, placebo-controlled, phase 3 trial of early vitamin D3 supplementation in critically ill, vitamin D-deficient patients who were at high risk for death. Randomization occurred within 12 hours after the decision to admit the patient to an intensive care unit. Eligible patients received a single enteral dose of 540,000 IU of vitamin D3 or matched placebo. The primary end point was 90-day all-cause, all-location mortality. RESULTS: A total of 1360 patients were found to be vitamin D-deficient during point-of-care screening and underwent randomization. Of these patients, 1078 had baseline vitamin D deficiency (25-hydroxyvitamin D level, <20 ng per milliliter [50 nmol per liter]) confirmed by subsequent testing and were included in the primary analysis population. The mean day 3 level of 25-hydroxyvitamin D was 46.9±23.2 ng per milliliter (117±58 nmol per liter) in the vitamin D group and 11.4±5.6 ng per milliliter (28±14 nmol per liter) in the placebo group (difference, 35.5 ng per milliliter; 95% confidence interval [CI], 31.5 to 39.6). The 90-day mortality was 23.5% in the vitamin D group (125 of 531 patients) and 20.6% in the placebo group (109 of 528 patients) (difference, 2.9 percentage points; 95% CI, -2.1 to 7.9; P = 0.26). There were no clinically important differences between the groups with respect to secondary clinical, physiological, or safety end points. The severity of vitamin D deficiency at baseline did not affect the association between the treatment assignment and mortality. CONCLUSIONS: Early administration of high-dose enteral vitamin D3 did not provide an advantage over placebo with respect to 90-day mortality or other, nonfatal outcomes among critically ill, vitamin D-deficient patients. (Funded by the National Heart, Lung, and Blood Institute; VIOLET ClinicalTrials.gov number, NCT03096314.).
Authors: David E Leaf; Anas Raed; Michael W Donnino; Adit A Ginde; Sushrut S Waikar Journal: Am J Respir Crit Care Med Date: 2014-09-01 Impact factor: 21.405
Authors: Camille E Powe; Michele K Evans; Julia Wenger; Alan B Zonderman; Anders H Berg; Michael Nalls; Hector Tamez; Dongsheng Zhang; Ishir Bhan; S Ananth Karumanchi; Neil R Powe; Ravi Thadhani Journal: N Engl J Med Date: 2013-11-21 Impact factor: 91.245
Authors: M K Thomas; D M Lloyd-Jones; R I Thadhani; A C Shaw; D J Deraska; B T Kitch; E C Vamvakas; I M Dick; R L Prince; J S Finkelstein Journal: N Engl J Med Date: 1998-03-19 Impact factor: 91.245
Authors: A Catharine Ross; JoAnn E Manson; Steven A Abrams; John F Aloia; Patsy M Brannon; Steven K Clinton; Ramon A Durazo-Arvizu; J Christopher Gallagher; Richard L Gallo; Glenville Jones; Christopher S Kovacs; Susan T Mayne; Clifford J Rosen; Sue A Shapses Journal: J Clin Endocrinol Metab Date: 2010-11-29 Impact factor: 5.958
Authors: Rachel C A Dancer; Dhruv Parekh; Sian Lax; Vijay D'Souza; Shengxing Zheng; Chris R Bassford; Daniel Park; D G Bartis; Rahul Mahida; Alice M Turner; Elizabeth Sapey; Wenbin Wei; Babu Naidu; Paul M Stewart; William D Fraser; Kenneth B Christopher; Mark S Cooper; Fang Gao; David M Sansom; Adrian R Martineau; Gavin D Perkins; David R Thickett Journal: Thorax Date: 2015-04-22 Impact factor: 9.139
Authors: Gennaro Martucci; Dayre McNally; Dhruv Parekh; Paul Zajic; Fabio Tuzzolino; Antonio Arcadipane; Kenneth B Christopher; Harald Dobnig; Karin Amrein Journal: Crit Care Date: 2019-06-04 Impact factor: 9.097
Authors: Ken Batai; Adam B Murphy; Ebony Shah; Maria Ruden; Jennifer Newsome; Sara Agate; Michael A Dixon; Hua Yun Chen; Leslie A Deane; Courtney M P Hollowell; Chiledum Ahaghotu; Rick A Kittles Journal: Hum Genet Date: 2014-08-02 Impact factor: 4.132
Authors: Patrick G Dougherty; Manjula Karpurapu; Amritendu Koley; Jessica K Lukowski; Ziqing Qian; Teja Srinivas Nirujogi; Luiza Rusu; Sangwoon Chung; Amanda B Hummon; Hao W Li; John W Christman; Dehua Pei Journal: J Med Chem Date: 2020-10-19 Impact factor: 7.446
Authors: Quirin Notz; Johannes Herrmann; Tobias Schlesinger; Peter Kranke; Magdalena Sitter; Philipp Helmer; Jan Stumpner; Daniel Roeder; Karin Amrein; Christian Stoppe; Christopher Lotz; Patrick Meybohm Journal: Clin Nutr Date: 2021-03-07 Impact factor: 7.643
Authors: George W Williams; Nathaniel K Berg; Alexander Reskallah; Xiaoyi Yuan; Holger K Eltzschig Journal: Anesthesiology Date: 2021-02-01 Impact factor: 7.892
Authors: Jakob J Malin; Christoph D Spinner; Uwe Janssens; Tobias Welte; Steffen Weber-Carstens; Gereon Schälte; Petra Gastmeier; Florian Langer; Martin Wepler; Michael Westhoff; Michael Pfeifer; Klaus F Rabe; Florian Hoffmann; Bernd W Böttiger; Julia Weinmann-Menke; Alexander Kersten; Peter Berlit; Marcin Krawczyk; Wiebke Nehls; Falk Fichtner; Sven Laudi; Miriam Stegemann; Nicole Skoetz; Monika Nothacker; Gernot Marx; Christian Karagiannidis; Stefan Kluge Journal: Infection Date: 2021-07-06 Impact factor: 3.553
Authors: Denise Battaglini; Chiara Robba; Andrea Fedele; Sebastian Trancǎ; Samir Giuseppe Sukkar; Vincenzo Di Pilato; Matteo Bassetti; Daniele Roberto Giacobbe; Antonio Vena; Nicolò Patroniti; Lorenzo Ball; Iole Brunetti; Antoni Torres Martí; Patricia Rieken Macedo Rocco; Paolo Pelosi Journal: Front Med (Lausanne) Date: 2021-06-04